4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001209191-22-050106
Options or other derivatives
- Executive Chairman acquired 525,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Reich Samuel J Executive Chairman | 2022-09-13 | Grant or award · Employee Stock Option (right to buy) | +525,000 | 525,000 | D | ||
Loading xslF345X03/doc4.xml…